quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:00·37d
PRRelease
Whitehawk Therapeutics Inc. logo

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

WHWK· Whitehawk Therapeutics Inc.
Health Care
Original source

Companies

  • WHWK
    Whitehawk Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 5UpdateOppenheimer$6.00

Related

  • PR4d
    Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
  • INSIDER6d
    SEC Form 4 filed by Giacobello Scott M.
  • PR7d
    Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
  • INSIDER8d
    SEC Form 4 filed by Ball Bryan
  • INSIDER10d
    SEC Form 4 filed by Ball Bryan
  • INSIDER13d
    SEC Form 4 filed by Lennon David James
  • PR14d
    Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
  • INSIDER15d
    SEC Form 4 filed by Lennon David James
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022